Top compounds associated with response to CCDC61


Feature Type Standardized
Nominal ANOVA
mRNA tretinoin:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.057 0.1
mRNA ETP-46464 CTRPv2 pan-cancer AAC -0.069 0.1
mRNA barasertib CTRPv2 pan-cancer AAC 0.052 0.1
mRNA navitoclax:piperlongumine (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.058 0.1
mRNA selumetinib:vorinostat (8:1 mol/mol) CTRPv2 pan-cancer AAC 0.058 0.1
mRNA I-BET-762 GDSC1000 pan-cancer AAC 0.039 0.1
mRNA AZD6244 UHNBreast pan-cancer AAC 0.42 0.2
mRNA dexamethasone CTRPv2 pan-cancer AAC -0.053 0.2
mRNA Methotrexate GDSC1000 pan-cancer AAC -0.042 0.2
mRNA Fumonisin B1 CTRPv2 pan-cancer AAC -0.059 0.2
Download CSV